TSC-LAM occurs in the setting of tuberous sclerosis complex (TSC), a multisystem genetic disorder characterized by mutations in TSC1 and TSC2, and is associated with additional clinical features including shagreen patches, facial angiofibromas, and recurrent seizures. This evidence concerns the gene TSC2 and lymphangioleiomyomatosis.